Gut-adipose tissue axis in hepatic fat accumulation in humans

Journal of Hepatology

Volumn 61, Issue 1, 2014, Pages 132-138

  Munukka, Eveliina ^a,b   Pekkala, Satu ^a   Wiklund, Petri ^a   Rasool, Omid ^c   Borra, Ronald ^d   Kong, Lingjia ^e   Ojanen, Xiaowei ^f   Cheng, Shu Mei ^a   Roos, Christophe ^e   Tuomela, Soile ^c   Alen, Markku ^g,h   Lahesmaa, Riitta ^c   Cheng, Sulin ^a,i  

^a UNIVERSITY OF JYVÄSKYLÄ   (Finland)

^b UNIVERSITY OF TURKU   (Finland)

^c TURKU CENTRE FOR BIOTECHNOLOGY   (Finland)

^d TURKU UNIVERSITY HOSPITAL   (Finland)

^e TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^f UNIVERSITY OF EASTERN FINLAND   (Finland)

^g OULU UNIVERSITY HOSPITAL   (Finland)

^h UNIVERSITY OF OULU   (Finland)

ⁱ SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Adipose tissue inflammation; Faecalibacterium prausnitzii; Leaky gut; Microbiota dysbiosis

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BIOLOGICAL MARKER; GELATINASE B; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LEPTIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MITOGEN ACTIVATED PROTEIN KINASE 10; MULTIDRUG RESISTANCE ASSOCIATED PROTEIN 3; RAB34 PROTEIN; RNA 16S; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ABDOMINAL FAT; ADIPOSE TISSUE; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; DYSBIOSIS; FAECALIBACTERIUM PRAUSNITZII; FEMALE; FLOW CYTOMETRY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN TISSUE; INFLAMMATION; INSULIN BLOOD LEVEL; LIPID STORAGE; MALE; MICROARRAY ANALYSIS; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; BLOOD; BODY COMPOSITION; CROSS-SECTIONAL STUDY; DIGESTIVE SYSTEM; INSULIN RESISTANCE; LIVER; METABOLISM; MICROBIOLOGY; MICROFLORA; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; PATHOLOGY;

ADIPOSE TISSUE; ADULT; BODY COMPOSITION; CROSS-SECTIONAL STUDIES; DIGESTIVE SYSTEM; FEMALE; GENE EXPRESSION; HUMANS; INFLAMMATION; INSULIN RESISTANCE; LIVER; MALE; MICROBIOTA; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; TRIGLYCERIDES;

EID: 84902679804     PISSN: 01688278     EISSN: 16000641     Source Type: Journal    
DOI: 10.1016/j.jhep.2014.02.020     Document Type: Article

References (44)

1. P. Angulo GI epidemiology: nonalcoholic fatty liver disease Aliment Pharmacol Ther 25 2007 883 889
2. M. Charlton Nonalcoholic fatty liver disease: a review of current understanding and future impact Clin Gastroenterol Hepatol 2 2004 1048 1058
3. K. Cusi Role of role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications Gastroenterology 142 2012 711 725
4. J. Tordjman, A. Divoux, E. Prifti, C. Poitou, V. Pelloux, and D. Hugol et al. Structural and inflammatory heterogeneity in subcutaneous adipose tissue: relation with liver histopathology in morbid obesity J Hepatol 56 2012 1152 1158
5. F. Bäckhed, H. Ding, T. Wang, L.V. Hooper, G.Y. Koh, and A. Nagy et al. The gut microbiota as an environmental factor that regulates fat storage Proc Natl Acad Sci U S A 101 2004 15718 15723
6. M. Mouzaki, E.M. Comelli, B.M. Arendt, J. Bonengel, S.K. Fung, and S.E. Fischer et al. Intestinal microbiota in patients with nonalcoholic fatty liver disease Hepatology 58 2013 120 127
7. L. Zhu, S. Baker, C. Gill, W. Liu, R. Alkhouri, and R.D. Baker et al. Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: a connection between endogenous alcohol and NASH Hepatology 57 2013 601 609
8. G. Son, M. Kremer, and I.N. Hines Contribution of gut bacteria to liver pathobiology Gastroenterol Res Pract 2010 1 13
9. L. Miele, V. Valenza, G. La Torre, M. Montalto, G. Cammarota, and R. Ricci et al. Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease Hepatology 49 2009 1877 1887
10. A. Lyytikäinen, C. Lamberg-Allardt, L. Kannas, and S. Cheng Food consumption and nutrient intakes with a special focus on milk product consumption in early pubertal girls in Central Finland Public Health Nutr 8 2005 284 289
11. E. Völgyi, F.A. Tylavsky, A. Lyytikäinen, H. Suominen, M. Alén, and S. Cheng Assessing body composition with DXA and bioimpedance: effects of obesity, physical activity, and age Obesity 16 2008 700 705
12. R.J.H. Borra, S. Salo, K. Dean, R. Lautamäki, P. Nuutila, and M. Komu et al. Nonalcoholic fatty liver disease: rapid evaluation of liver fat content with in-phase and out-of-phase MR imaging Radiology 250 2009 130 136
13. W. Shen, M. Punyanitya, Z. Wang, D. Gallagher, M.P. St-Onge, and J. Albu et al. Visceral adipose tissue: relations between single-slice areas and total volume Am J Clin Nutr 80 2004 271 278
14. N. Abate, A. Garg, R. Coleman, S.M. Grundy, and R.M. Peshock Prediction of total subcutaneous abdominal, intraperitoneal, and retroperitoneal adipose tissue masses in men by a single axial magnetic resonance imaging slice Am J Clin Nutr 65 1997 403 408
15. J. Vaahtovuo, M. Korkeamäki, E. Munukka, M.K. Viljanen, and P. Toivanen Quantification of bacteria in human feces using 16S rRNA-hybridization, DNA-staining and flow cytometry J Microbiol Methods 63 2005 276 286
16. J. Vaahtovuo, M. Korkeamäki, E. Munukka, P. Hämeenoja, and J. Vuorenmaa Microbial balance index - A view on the intestinal microbiota Livestock Sci 109 2007 174 178
17. E. Munukka, P. Wiklund, S. Pekkala, E. Völgyi, L. Xu, and S. Cheng et al. Women with and without metabolic disorder differ in their gut microbiota composition Obesity (Silver Spring) 20 2012 1082 1087
18. B. Bolstad, R. Irizarry, M. Astrand, and T. Speed A comparison of normalization methods for high density oligonucleotide array data based on bias and variance Bioinformatics 19 2003 185 193
19. R. Gentleman, V. Carey, D. Bates, B. Bolstad, D. Dettling, and S. Dudoit et al. Bioconductor: open software development for computational biology and bioinformatics Genome Biol 5 2004 R80
20. R. Ihaka, and R. Gentleman R: a language for data analysis and graphics J Comput Graph Stat 5 1996 299 314
21. L. Gautier, L. Cope, B.M. Bolstad, and R.A. Irizarry Affy-analysis of Affymetrix GeneChip data at the probe level Bioinformatics 20 2004 307 315
22. G. Smyth, N. Thorne, and J. Wettenhall Limma: linear models for microarray data 2005 in bioinformatics and computational biology solutions using R and bioconductor 2005 Springer New York [p. 397-420]
23. Y. Benjamini, and D. Yekutieli The control of the false discovery rate in multiple testing under dependency Ann Stat 29 2001 1165 1188
24. H. Sokol, L. Pigneur, L. Watterlot, O. Lakhdari, L.G. Bermundez-Humara, and J.-J. Gratadoux et al. Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients Proc Natl Acad Sci U S A 105 2008 16731 16763
25. E. Le Chatelier, T. Nielsen, J. Qin, E. Prifti, F. Hildebrand, and G. Falony et al. Richness of human gut microbiome correlates with metabolic markers Nature 500 2013 541 546
26. S. Miquel, R. Martin, O. Rossi, L.G. Bermudez-Humaran, J.M. Chatel, and H. Sokol et al. Faecalibacterium prausnitzii and human intestinal health Curr Opin Microbiol 16 2013 255 261
27. P.D. Cani, R. Bibiloni, C. Knauf, A. Waget, A.M. Neyrinck, and D. Delzenne et al. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice Diabetes 57 2008 1470 1481
28. A. Bernhardt, D. Kuester, A. Roessner, T. Reinheckel, and S. Krueger Cathepsin X-deficient gastric epithelial cells in co-culture with macrophages: characterization of cytokine response and migration capability after Helicobacter pylori infection J Biol Chem 285 2010 33691 33700
29. R. Paolillo, M.R. Iovene, C. Romano Carratelli, and A. Rizzo Induction of VEGF and MMP-9 expression by toll-like receptor 2/4 in human endothelial cells infected with Chlamydia pneumoniae Int J Immunopathol Pharmacol 25 2012 377 386
30. T. Watanabe, J. Masuyama, Y. Sohma, H. Inazawa, K. Horie, and K. Kojima et al. CD52 is a novel costimulatory molecule for induction of CD4+ regulatory T cells Clin Immunol 120 2006 247 259
31. R. Singh, A. Jamieson, and P. Cresswell GILT is a critical host factor for Listeria monocytogenes infection Nature 455 2008 1244 1247
32. W.K. Glowacka, P. Alberts, R. Ouchida, J.Y. Wang, and D. Rotin LAPTM5 protein is a positive regulator of proinflammatory signaling pathways in macrophages J Biol Chem 287 2012 27691 27702
33. K. Hosoki, A. Nakamura, M. Nagao, Y. Hiraguchi, H. Tanida, and R. Tokuda et al. Staphylococcus aureus directly activates eosinophils via platelet-activating factor receptor J Leukoc Biol 92 2012 333 341
34. D.P. Brown, D.C. Jones, K.J. Anderson, N. Lapaque, R.A. Buerki, and J. Trowsdale et al. The inhibitory receptor LILRB4 (ILT3) modulates antigen presenting cell phenotype and, along with LILRB2 (ILT4), is upregulated in response to Salmonella infection BMC Immunol 10 2009 56
35. Y. Fukui, O. Hashimoto, T. Sanui, T. Oono, H. Koga, and M. Abe et al. Haematopoietic cell-specific CDM family protein DOCK2 is essential for lymphocyte migration Nature 412 2001 826 831
36. B. Kasmapour, A. Gronow, C.K. Bleck, W. Hong, and M.G. Gutierrez Size-dependent mechanism of cargo sorting during lysosome-phagosome fusion is controlled by Rab34 Proc Natl Acad Sci U S A 109 2013 20485 20490
37. H. Fan, A. Bitto, B. Zingarelli, L.M. Luttrell, K. Borg, and P.V. Halushka et al. Beta-arrestin 2 negatively regulates sepsis-induced inflammation Immunology 130 2010 344 351
38. B. Roppenser, A. Roder, M. Hentschke, K. Ruckdeschel, and M. Aepfelbacher Yersinia enterocolitica differentially modulates RhoG activity in host cells J Cell Sci 122 2009 696 705
39. P.D. Cani, S. Possemiers, T. Van de Wiele, Y. Guiot, A. Everard, and O. Rottier et al. Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability Gut 2009 2009 1091 1103
40. J. Amar, C. Chabo, A. Waget, P. Klopp, C. Vachoux, and L.G. Bermudez-Humaran et al. Intestinal mucosal adherence and translocation of commensal bacteria at the early onset of type 2 diabetes: molecular mechanisms and probiotic treatment EMBO Mol Med 3 2011 559 572
41. S. Libreros, R. Garcia-Areas, Y. Shibata, R. Carrio, and M. Torroella-Kouri Iragavarapu Charyulu V. Induction of proinflammatory mediators by CHI3L1 is reduced by chitin treatment: decreased tumor metastasis in a breast cancer model Int J Cancer 131 2012 377 386
42. L. Zhang, Y. Tang, Y. Tie, C. Tian, J. Wang, and Y. Dong et al. The PH domain containing protein CKIP-1 binds to IFP35 and Nmi and is involved in cytokine signaling Cell Signal 19 2007 932 944
43. E. Griffith, A.S. Coutts, and D.M. Black RNAi knockdown of the focal adhesion protein TES reveals its role in actin stress fibre organisation Cell Motil Cytoskeleton 60 2005 140 152
44. F.H. Karlsson, V. Tremaroli, I. Nookaew, G. Bergström, C.J. Behre, and B. Fagerberg et al. Gut metagenome in European women with normal, impaired and diabetic glucose control Nature 498 2013 99 103